1. Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
- Author
-
Candito, David A., primary, Simov, Vladimir, additional, Gulati, Anmol, additional, Kattar, Solomon, additional, Chau, Ryan W., additional, Lapointe, Blair T., additional, Methot, Joey L., additional, DeMong, Duane E., additional, Graham, Thomas H., additional, Kurukulasuriya, Ravi, additional, Keylor, Mitchell H., additional, Tong, Ling, additional, Morriello, Gregori J., additional, Acton, John J., additional, Pio, Barbara, additional, Liu, Weiguo, additional, Scott, Jack D., additional, Ardolino, Michael J., additional, Martinot, Theodore A., additional, Maddess, Matthew L., additional, Yan, Xin, additional, Gunaydin, Hakan, additional, Palte, Rachel L., additional, McMinn, Spencer E., additional, Nogle, Lisa, additional, Yu, Hongshi, additional, Minnihan, Ellen C., additional, Lesburg, Charles A., additional, Liu, Ping, additional, Su, Jing, additional, Hegde, Laxminarayan G., additional, Moy, Lily Y., additional, Woodhouse, Janice D., additional, Faltus, Robert, additional, Xiong, Tina, additional, Ciaccio, Paul, additional, Piesvaux, Jennifer A., additional, Otte, Karin M., additional, Kennedy, Matthew E., additional, Bennett, David Jonathan, additional, DiMauro, Erin F., additional, Fell, Matthew J., additional, Neelamkavil, Santhosh, additional, Wood, Harold B., additional, Fuller, Peter H., additional, and Ellis, J. Michael, additional
- Published
- 2022
- Full Text
- View/download PDF